Framingham Heart Study Brain Aging Program to Host Clinical Neuropathology Case Conference

The Framingham Heart Study Brain Aging Program will host its upcoming Clinical Neuropathology Case Conference on April 10, 2026, from 10:00 AM to 12:00 PM.

This interactive session, organize

d by the program’s Clinical and Neuropathology Cores, will feature four compelling cases highlighting clinical history, neuroimaging, and neuropathological findings. Each case will explore the alignment—and at times discrepancy—between clinical diagnoses and neuropathological outcomes, fostering discussion aimed at improving diagnostic accuracy.

These conferences play a vital role in strengthening collaboration between clinical and neuropathology teams, ultimately contributing to more precise assessment methods and advancing future treatments in brain aging and neurodegenerative disease.

The event will be held virtually. Registration is required.

https://bu-hipaa.zoom.us/webinar/register/WN_6WHzlVaCRTKns67a9Sv-EQ#/registration 

Plasma p-tau181 shows stronger network association to Alzheimer’s disease dementia than neurofilament light and total tau

Frank B, Ally M, Brekke B, Zetterberg H, Blennow K, Sugarman MA, Ashton NJ, Karikari T, Tripodis Y, Martin B, Palmisano JN, Steinberg EG, Simkin I, Turk KW, Budson AE, O’Connor MK, Au R, Goldstein LE, Jun GR, Kowall NW, Stein TD, McKee AC, Killiany R, Qiu WQ, Stern RA, Mez J, Alosco ML. Plasma p-tau181 shows stronger network association to Alzheimer's disease dementia than neurofilament light and total tau. Alzheimer Dement 2022; 98:e2454-e2464.

Read More

NIH Grant Will Establish New Framingham Heart Study Brain Aging Program

Since 1976, the Framingham Heart Study (FHS)–the longest running multi-generational epidemiological study in the world–has followed participants for incident dementia.

Thanks to a five-year, $26.56 million grant from the National Institutes of Health, a new program called the Framingham Heart Study Brain Aging Program (FHS-BAP) will continue the surveillance and evaluation of FHS participants for dementia (including cognitive assessments and brain imaging) and invigorate the FHS brain donation program and brain bank. The program will also establish a platform to promote data sharing that will accelerate AD research using FHS data and conduct three interrelated projects using FHS data and specimen resources.

Read More

Rhoda Au Receives $2.8M Award from AHA, Bill Gates

The American Heart Association — the world’s leading voluntary organization dedicated to a world of longer, healthier lives — and global philanthropist and technology visionary Bill Gates, have committed to advancing the scientific evidence base related to brain health and dementia by funding a $3.3 million health technology research joint initiative. The project will specifically fund a new brain health and dementia technology research center at Boston University. Additionally, it will support the global exchange of research data to help scientists around the world collectively work in accelerating new discoveries related to heart and brain health, including the early detection and treatment of Alzheimer’s disease and related dementias.

Read More